Assesment of "Dawa al-Blaghm" on liver enzymes in patients with fatty liver - Trial IRCT2017073135415N1
Access comprehensive clinical trial information for IRCT2017073135415N1 through Pure Global AI's free database. This phase not specified trial is sponsored by Vice chancellor for research, Qom University of Medical Sciences and is currently Completed. The study focuses on Nonalcoholic fatty liver disease (NAFLD).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
IRCT2017073135415N1
Completed
drug
Trial Details
Iranian Registry Of Clinical Trial • IRCT2017073135415N1
Assesment of "Dawa al-Blaghm" on liver enzymes in patients with fatty liver
Evaluation of the effect of Dva’-Albalgham ,on serum levels of liver enzymes in patients with NAFLD.
Study Focus
Sponsor & Location
Vice chancellor for research, Qom University of Medical Sciences
Iran
Timeline & Enrollment
N/A
Aug 21, 2017
N/A
ICD-10 Classifications
Liver disease, unspecified
Inflammatory liver disease, unspecified
Alcoholic liver disease, unspecified
Alcoholic fatty liver
Toxic liver disease, unspecified
Data Source
Iranian Registry Of Clinical Trial
IRCT2017073135415N1
Non-Device Trial